These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15086559)

  • 21. Omega-O-acylceramide, a lipid essential for mammalian survival.
    Uchida Y; Holleran WM
    J Dermatol Sci; 2008 Aug; 51(2):77-87. PubMed ID: 18329855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucosylceramides stimulate mitogenesis in aged murine epidermis.
    Marchell NL; Uchida Y; Brown BE; Elias PM; Holleran WM
    J Invest Dermatol; 1998 Apr; 110(4):383-7. PubMed ID: 9540979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
    Yamaguchi Y; Sasagasako N; Goto I; Kobayashi T
    J Biochem; 1994 Sep; 116(3):704-10. PubMed ID: 7852294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis.
    Jennemann R; Sandhoff R; Langbein L; Kaden S; Rothermel U; Gallala H; Sandhoff K; Wiegandt H; Gröne HJ
    J Biol Chem; 2007 Feb; 282(5):3083-94. PubMed ID: 17145749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.
    Haller JF; Cavallaro P; Hernandez NJ; Dolat L; Soscia SJ; Welti R; Grabowski GA; Fitzgerald ML; Freeman MW
    J Lipid Res; 2014 Mar; 55(3):493-503. PubMed ID: 24293640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingolipid metabolism during epidermal barrier development in mice.
    Doering T; Brade H; Sandhoff K
    J Lipid Res; 2002 Oct; 43(10):1727-33. PubMed ID: 12364557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of skin barrier abnormalities and epidermal ceramide profiles among three ω-O-acylceramide synthesis-deficient mouse strains.
    Yamamoto Y; Sassa T; Kihara A
    J Dermatol Sci; 2024 Jan; 113(1):10-17. PubMed ID: 38158274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier.
    Pichery M; Huchenq A; Sandhoff R; Severino-Freire M; Zaafouri S; Opálka L; Levade T; Soldan V; Bertrand-Michel J; Lhuillier E; Serre G; Maruani A; Mazereeuw-Hautier J; Jonca N
    Hum Mol Genet; 2017 May; 26(10):1787-1800. PubMed ID: 28369476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid Metabolic Events Underlying the Formation of the Corneocyte Lipid Envelope.
    Wertz PW
    Skin Pharmacol Physiol; 2021; 34(1):38-50. PubMed ID: 33567435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucosylceramides stimulate murine epidermal hyperproliferation.
    Marsh NL; Elias PM; Holleran WM
    J Clin Invest; 1995 Jun; 95(6):2903-9. PubMed ID: 7769132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in ceramides and glucosylceramides in mouse skin and human epidermal equivalents by rice-derived glucosylceramide.
    Shimoda H; Terazawa S; Hitoe S; Tanaka J; Nakamura S; Matsuda H; Yoshikawa M
    J Med Food; 2012 Dec; 15(12):1064-72. PubMed ID: 23216108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
    Kihara A
    Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis.
    Akiyama M
    J Dermatol Sci; 2017 Oct; 88(1):3-9. PubMed ID: 28623042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of glucosylceramide-based liposomes increased the ceramide content in a three-dimensional cultured skin epidermis.
    Tokudome Y; Endo M; Hashimoto F
    Skin Pharmacol Physiol; 2014; 27(1):18-24. PubMed ID: 23887587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.
    Hirabayashi T; Anjo T; Kaneko A; Senoo Y; Shibata A; Takama H; Yokoyama K; Nishito Y; Ono T; Taya C; Muramatsu K; Fukami K; Muñoz-Garcia A; Brash AR; Ikeda K; Arita M; Akiyama M; Murakami M
    Nat Commun; 2017 Mar; 8():14609. PubMed ID: 28248300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of essential fatty acid deficiency on epidermal O-acylsphingolipids and transepidermal water loss in young pigs.
    Melton JL; Wertz PW; Swartzendruber DC; Downing DT
    Biochim Biophys Acta; 1987 Sep; 921(2):191-7. PubMed ID: 3651483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant PNPLA1 catalyzes the synthesis of acylceramides and acyl acids with selective incorporation of linoleic acid.
    Meyer JM; Boeglin WE; Brash AR
    J Lipid Res; 2023 Jun; 64(6):100379. PubMed ID: 37087101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets.
    Senkal CE; Salama MF; Snider AJ; Allopenna JJ; Rana NA; Koller A; Hannun YA; Obeid LM
    Cell Metab; 2017 Mar; 25(3):686-697. PubMed ID: 28273483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.
    McEachern KA; Fung J; Komarnitsky S; Siegel CS; Chuang WL; Hutto E; Shayman JA; Grabowski GA; Aerts JM; Cheng SH; Copeland DP; Marshall J
    Mol Genet Metab; 2007 Jul; 91(3):259-67. PubMed ID: 17509920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.